CAMARILLO, Calif. and
WILMINGTON, Del., Dec. 14, 2016 /PRNewswire/ -- DuPont
Nutrition & Health and Hygiena, a Warburg Pincus portfolio
company that specializes in rapid food safety and environmental
sanitation testing, announced today that Hygiena will acquire
DuPont's global food safety diagnostics business. The acquisition
includes all of DuPont Diagnostics business assets, including the
BAX® and RiboPrinter® Systems and associated test kits; a global
and technically trained sales, R&D and manufacturing
organization; and in-house production capacity. The business was
formed by DuPont in 1992 as Qualicon, and Hygiena will retain the
Qualicon name. The transaction is expected to close in the first
quarter of 2017, pending customary closing conditions, including
regulatory approvals. Financial terms of the agreement were
not disclosed.
DuPont Diagnostics provides innovative, science-based microbial
detection and monitoring products that identify and characterize
pathogens and other unwelcome organisms in food ingredients,
finished products and production environments. Shortly after the
formation of the business, DuPont pioneered Nobel-prize-winning PCR
technology in commercial food safety testing with the BAX® System
for pathogen detection. Today, the BAX® System has been
adopted as the leading detection method by food manufacturers, food
quality laboratories and governments around the world. Hygiena
plans to invest behind new product development to continue the
DuPont Diagnostics history of market-leading innovation.
"The combination of DuPont Diagnostics and Hygiena will create a
broad food safety diagnostics company that can better serve our
customers," said Steve Nason, chief
executive officer of Hygiena. "The combined company's
microbiology products will cover the full manufacturing process,
from in-process environmental tests to finished product tests. In
addition, the combination increases our customer service presence
in the United States and
internationally, which will allow us to further enhance our
research and development efforts and support to our combined
customer base."
"This transaction is a strategic business decision that will
allow DuPont Nutrition & Health to focus on growth
opportunities that are more closely aligned with our core portfolio
of specialty food ingredients," said Matthias Heinzel, president, DuPont Nutrition
& Health. "We believe that the Diagnostics business is an
excellent strategic fit with Hygiena. Together they will be
better able to offer greater opportunities for growth and
investment in innovative solutions for the global pathogen testing
industry."
Hygiena is a microbiology and life science company that serves
industrial food processors, healthcare institutions, life science
researchers and other industries. Hygiena manufactures and sells a
broad range of rapid hygiene monitoring systems, environmental
collection systems and rapid dilution devices, including its market
leading ATP (adenosine triphosphate) testing system. Its
products are distributed in over 80 countries worldwide. Hygiena is
committed to the mission of providing customers with innovative
technologies that are simple, easy to use and reliable, with
excellent customer service and support.
In 2016, Hygiena received an investment from Warburg Pincus, a
global private equity firm focused on growth investing, to help
further this mission. Warburg Pincus' investment in Hygiena
was driven by the firm's thesis that the company represents an
excellent platform to consolidate the highly fragmented food and
life sciences testing and environmental sanitation industry.
Stephanie Geveda, managing director, Warburg Pincus, said,
"DuPont Diagnostics is a perfect fit within Hygiena's growth
strategy. We are excited to invest in and build upon the
business' portfolio of leading diagnostic products and
capabilities."
About Hygiena
Hygiena LLC (www.hygiena.com) is a
microbiology and life science company that serves industrial food
processors, healthcare institutions, life science researchers and
other industries. Utilizing advanced technologies and patented
designs, Hygiena manufactures a broad range of rapid hygiene
monitoring systems, environmental collection systems, rapid
dilution devices, and more. All products are made under strict GMP
standards in its ISO-certified facility, ensuring excellent product
quality and reliability. Hygiena is committed to the mission of
providing customers with innovative technologies that are simple,
easy to use, and reliable, with excellent customer service and
support. Hygiena is headquartered in the
United States in Camarillo,
Calif., with satellite offices in the United Kingdom and China. With over 100 distributors in 80
countries worldwide, Hygiena products span the globe.
About Warburg Pincus
Warburg Pincus LLC is a leading
global private equity firm focused on growth investing. The firm
has more than $40 billion in private
equity assets under management. The firm's active portfolio of more
than 120 companies is highly diversified by stage, sector and
geography. Warburg Pincus is an experienced partner to management
teams seeking to build durable companies with sustainable value.
Founded in 1966, Warburg Pincus has raised 15 private equity funds,
which have invested more than $58
billion in over 760 companies in more than 40 countries. The
firm is headquartered in New York
with offices in Amsterdam,
Beijing, Hong Kong, London, Luxembourg, Mumbai, Mauritius, San
Francisco, São Paulo, Shanghai, and Singapore. For more information, please visit
www.warburgpincus.com.
About DuPont
DuPont (NYSE: DD) has been bringing
world-class science and engineering to the global marketplace in
the form of innovative products, materials, and services since
1802. The company believes that by collaborating with
customers, governments, NGOs, and thought leaders we can help find
solutions to such global challenges as providing enough healthy
food for people everywhere, decreasing dependence on fossil fuels,
and protecting life and the environment. For additional
information about DuPont, please visit www.dupont.com.
Forward-Looking Statements: This communication contains
"forward-looking statements" within the meaning of the federal
securities laws, including Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended. In this context, forward-looking statements often
address expected future business and financial performance and
financial condition, and often contain words such as "expect,"
"anticipate," "intend," "plan," "believe," "seek," "see," "will,"
"would," "target," similar expressions, and variations or negatives
of these words. Forward-looking statements by their nature address
matters that are, to different degrees, uncertain, such as
statements about the consummation of the proposed transaction and
the anticipated benefits thereof. Forward-looking statements are
not guarantees of future performance and are based on certain
assumptions and expectations of future events which may not be
realized. Forward-looking statements also involve risks and
uncertainties, many of which are beyond the company's control. Some
of the important factors that could cause the company's actual
results to differ materially from those projected in any such
forward-looking statements are: fluctuations in energy and raw
material prices; failure to develop and market new products and
optimally manage product life cycles; ability to respond to market
acceptance, rules, regulations and policies affecting products
based on biotechnology and, in general, for products for the
agriculture industry; outcome of significant litigation and
environmental matters, including realization of associated
indemnification assets, if any; failure to appropriately manage
process safety and product stewardship issues; changes in laws and
regulations or political conditions; global economic and capital
markets conditions, such as inflation, interest and currency
exchange rates; business or supply disruptions; security threats,
such as acts of sabotage, terrorism or war, natural disasters and
weather events and patterns which could affect demand as well as
availability of products for the agriculture industry; ability to
protect and enforce the company\'s intellectual property rights;
successful integration of acquired businesses and separation of
underperforming or non-strategic assets or businesses; and risks
related to the agreement entered on December
11, 2015, with The Dow Chemical Company pursuant to which
the companies have agreed to effect an all-stock merger of equals,
including the completion of the proposed transaction on anticipated
terms and timing, the ability to fully and timely realize the
expected benefits of the proposed transaction and risks related to
the intended business separations contemplated to occur after the
completion of the proposed transaction. The company undertakes no
duty to publicly revise or update any forward-looking statements as
a result of future developments, or new information or otherwise,
should circumstances change, except as otherwise required by
securities and other applicable laws.
The DuPont Oval logo, DuPont™ and all
products, unless otherwise noted, denoted with
™, SM or ® are
trademarks or registered trademarks of E.I. du Pont de Nemours and
Company or its affiliates.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hygiena-to-acquire-food-safety-diagnostics-business-from-dupont-300378105.html
SOURCE DuPont